| September 30, 2021
Improving your ADC’s chance of clinical success requires an understanding of what potential obstacles lie ahead and what capabilities and expertise are necessary to overcome them.
Despite the potential of ADCs and other bioconjugates, they present a wide range of challenges for drug developers and manufacturers trying to navigate their way to commercial success.
Explore the complexity and uncertainty that defines the bioconjugates market and how companies can position themselves to mitigate that uncertainty at every stage of development.
Working with a partner that can provide a one-stop shop for bioconjugate development and manufacturing can help to prevent missteps that could threaten your ability to deliver life-saving drugs to patients who need them.
Drug developers must successfully navigate a novel drug’s path to market under the growing pressure of regulation and competition, and while carefully managing technical and financial risk.